NCT01579526View on ClinicalTrials.gov

A Single Dose Study to Determine the Safety and Pharmacokinetics of FP01 Lozenges in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

April 30, 2012

Study Completion Date

May 31, 2012

Conditions
Healthy
Interventions
DRUG

FP01

comparison of different dosages

Trial Locations (1)

55114

Prism Research, Saint Paul

Sponsors
All Listed Sponsors
lead

Avalo Therapeutics, Inc.

INDUSTRY

NCT01579526 - A Single Dose Study to Determine the Safety and Pharmacokinetics of FP01 Lozenges in Healthy Volunteers | Biotech Hunter | Biotech Hunter